An Austrian study led by MedUni Vienna showed a partial or complete regression of brain metastasis in breast cancer patients after treatment with trastuzumab deruxtecan (T-Dxd).
The Latest
Oncologists’ average income rose about 2 percent to $411,000 in 2022, according to Medscape's "Oncologist Wealth & Debt Report," published Aug. 5.
President Joe Biden will appoint Monica Bertagnolli, MD, as the new director of the National Cancer Institute.
Chicago-based Northwestern Medicine expanded its cancer care to Chicago's south suburbs with the opening of the Northwestern Cancer Center Orland Park Aug. 9.
New York City-based Mount Sinai has been awarded a three-year, $500,000 grant from Stand Up To Cancer to explore therapeutic approaches to lung tumors with KRAS gene mutations.
Mayo Clinic Jacksonville (Fla.) began site work on its $233 million integrated oncology building, The Jacksonville Daily Record reported Aug. 8.
Morganstown, W. Va-based WVU Cancer Institute became the first facility in the state to administer Pluvicto, a radiation pharmaceutical administered through injection or infusion, for a type of metastatic prostate cancer, local news website My Buckhannon reported Aug. 7.
Here are four cancer research donations and grants over $5 million that Becker's has covered since June 15:
The FDA approved Enhertu Aug. 6, the first targeted therapy for HER2-low breast cancer.
The University of Virginia Cancer Center received gifts totaling $5.75 million from anonymous donors to speed the development of new treatments for rare blood cancers, according to an Aug. 4 press release from the university.